Calliditas Therapeutics
Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients.
Sweden
242 employees
Post Ipo Debt
Total: $311.00M
Biotechnology, Medical Devices +1
General Information
Get notified when Calliditas Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Calliditas Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Sweden Market
Biotechnology
About Calliditas Therapeutics
Taxonomy: rare diseases, specialty pharmaceutical, medical needs, pharmaceutical development, commercial expertise, treatment innovation, management team, unmet medical needs, scientific expertise, marketing strategy
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | •••••• | 1 |
|
27 Dec 2023 |
| Debt Financing | •••••• | 1 |
|
15 Jul 2021 |
| Venture Round | •••••• | - | 01 Oct 2015 | |
| Series C | •••••• | 1 |
|
03 Oct 2013 |
| Venture Round | •••••• | 1 |
|
04 Jan 2012 |
Calliditas Therapeutics Alternatives & Competitors
Discover a wide range of pharmaceutical solutions from manufacturing to export, catering to all your...
AFD Pharma is a global pharmaceutical company, focused on delivering high-quality medication and ser...
Forte Bio-Pharma is a privately held specialty pharmaceutical company focused on in-licensing, devel...
vs
-(OTCQX:CPHRF)-logo.jpg){kind=logo}
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF)
FAQ About Calliditas Therapeutics
Don't just browse. Track.
Signal Tracker monitors Calliditas Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.